Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > SIGA SIGA Technologies > Company Profile
SIGA SIGA Technologies
24.800
+1.900+8.30%
Symbol
SIGA
Company Name
SIGA Technologies, Inc.
Establishment Date
1995
CEO
Gomez III, M.D., Ph.D., Phillip Louis
Market
NASDAQ
Employees
39
Securities Type
Ordinary Shares
Fiscal Year Ends
December 31
Address
31 East 62nd Street
City
New York
Province
New York
Country
United States of America
Zip code
10065
Phone
1-212-672-9100
Profile
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
Company Overview
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
CEO: Gomez III, M.D., Ph.D., Phillip Louis
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top